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Background
Regulatory T cells (Tregs) are potent modulators of immu-
nity and may have an impact on T cell regulation and acti-
vation in the setting of HIV-1 infection. However, studies
on Tregs in HIV-1 infection have shown divergent results
and the exact role of Tregs in HIV-1 infection remains
poorly understood. We here investigated Treg frequencies,
immune activation and HIV-1 specific immunity in elite
controllers (EC) and chronic progressors.
Methods
We studied the frequency of CD4+CD25+FoxP3+ Tregs in
16 HIV-1 elite controllers (HIV-RNA <50 copies/ml), 17
individuals with untreated chronic progressive HIV-1
infection and 9 HIV negative individuals by flowcytomet-
ric analysis. We also evaluated T cell activation by meas-
urement of CD38 and HLA-DR expression on CD8 and
CD4 T lymphocytes. HIV-1 specific CD8 T cell responses
were available for a subset of individuals.
Results
In concordance with previous data, EC had significantly
lower immune activation than chronic progressors (p <
0.005). The frequency of CD4+CD25+FoxP3+ regulatory T
cells was positively correlated with T cell activation as
measured by frequency of CD8+CD38+ T cells (R2 0.42, P
= 0.006). There was a strong trend to decreased Treg fre-
quencies in elite controllers and HIV negative individuals
compared to chronic progressors. In the elite controller
subset HLA-B57 positive EC had lower Treg frequencies
than non-HLA-B57 EC, but this trend did not reach statis-
tical significance.
Conclusion
Our data suggest that Treg frequencies positively correlate
with immune activation in this cohort of individuals with
chronic HIV-1 infection and that elite control is associated
with lower T cell activation as previously described. Treg
frequencies may be lower in HIV-1 elite controllers com-
pared to chronic progressors but further studies are
needed to investigate this finding in more detail and to
address the impact of Tregs on HIV-1 specific T cell
responses.
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